Home Studieinformatie Studies in voorbereiding

Myeloproliferatieve neoplasie├źn (MPN)

TRANSFORM-1: A randomized, double-blind, placebo-controlled, phase 3 study of navitoclax in combination with ruxolitinib versus ruxolitinib in subjects with myelofibrosis

Multipel myeloom

ICON study: A phase 2 study of CC220 (iberdomide) combined with low-dose cyclophosphamide and dexamethasone in relapsed/refractory multiple myeloma (IberCd)

Supportive care

DUET2: Azole-echinocandin combination therapy for invasive aspergillosis. A randomized pragmatic superiority trial

ReSPECT: A phase 3, multicenter, randomized, double-blind study of the efficacy and safety of rezafungin for injection versus the standard antimicrobial regimen to prevent invasive fungal diseases in adults undergoing allogeneic blood and marrow transplantation


TAP-100: Validation TAP-100 blood collection device

HISTORY: Hypoplasminogenemia: an international retrospective and prospective cohort study

OPTI-CLOT: To WiN: Implementation of pharmacokinetic-guided dosing of DDAVP and VWF-containing concentrates in von Willebrand disease


SCORE: Sickle cell outcome research

Sickle cell screen: Investigating red blood cell deformability of sickle cell patients before and after the start of therapy


Ga terug naar de algemene homepage Studieprotocollen.